Denmark vs Ireland: Access to anti-retroviral drugs, female
Denmark
91.0%
in 2023
Ireland
90.0%
in 2023
Denmark rank
25th
Ireland rank
27th
Access to anti-retroviral drugs, female over time
- Denmark
- Ireland
How they compare
Denmark currently reports 91.0% against 90.0% in Ireland, a difference of 1.0%.
The two have swapped places 3 times across 24 shared years of data; in 2000 it was Ireland ahead.
Denmark ranks 25th and Ireland ranks 27th of 141 countries.
Across the 3 decades both report, Denmark averaged higher in 1 and Ireland in 2.
Head to head by decade
| Decade | Denmark | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.0% | 63.1% | 12.1% | Ireland |
| 2010s | 77.9% | 76.3% | 1.6% | Denmark |
| 2020s | 88.0% | 88.8% | 0.8% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Denmark or Ireland?
- Denmark, at 91.0% against 90.0% in Ireland as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Denmark and Ireland?
- 1.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Ireland?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Ireland rank globally for access to anti-retroviral drugs, female?
- Denmark ranks 25th and Ireland ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.